Tag: MediLynx

MediLynx Cardiac Monitoring Partners with National Heart, Lung and Blood Institute & National Institutes of Health on Study of Efficacy of Mobile Cardiac Monitoring for Patients

PLANO, Texas, Feb. 8, 2022 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics™), a national remote monitoring provider and technology leader in deep learning artificial intelligence, today announced a groundbreaking partnership with the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes […]

MediLynx Cardiac Monitoring, LLC introduces dedicated remote monitoring services based on its PocketECG® platform to support hospitals in managing COVID-19 patients in accordance with the latest FDA enforcement policy

PocketECG, MediLynx’s FDA approved remote monitoring systems: PocketECG Unified Arrhythmia Diagnostic System will be used for continuous streaming and analysis of full-disclosure ECG data, oxygen saturation, resting heart rate, patient symptoms and arrhythmia. The device is cleared by the FDA […]